Polymerase chain reaction-based molecular assays are gaining increasing importance in the diagnosis and monitoring of infectious diseases. Over the past several years, the development and application of these techniques has initiated a revolution in the diagnosis and monitoring of hepatitis C infection. Presently, molecular assays are exclusively done in especially dedicated laboratories. Advances in automation will bring these technologies into routine diagnostic laboratories and will make them widely used.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1515/CCLM.1998.100 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!